Sentante
Latest round
- Seed
Last raised
- Dec 2023
Total raised
- $6.5M
Investors
- 2
About Sentante
Founded in 2017 and based in Kaunas, Lithuania, Sentante provides a fully robotic teleoperated system for endovascular interventions. The company was co-founded by Edvardas Satkauskas (CEO), Dr. Tomas Baltrunas (CMO), and Dr. Evaldas Kalvaitis (COO). The company offers Sentante which is a robotic system for endovascular procedures. Sentante is a teleoperated robotic system that is intelligent and sensitive. It enables remote surgery from a separate room, shielding doctors from dangerous X-rays and creating new opportunities for telesurgery.
Who invested in Sentante
2 investors across 1 round
See all investors in Sentante
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Dec 21, 2023
Amount
$6.5M
Investors
Questions about Sentante
Who invested in Sentante?
Sentante has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sentante raised?
Sentante has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sentante last raise money?
Sentante's most recent round on record is a Seed, in Dec 2023.
What does Sentante do?
Founded in 2017 and based in Kaunas, Lithuania, Sentante provides a fully robotic teleoperated system for endovascular interventions.
Where is Sentante headquartered?
Sentante is headquartered in Kaunas, Lithuania.
Which VCs invest in companies like Sentante?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Sentante's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Sentante? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.